Sermorelin 5 mg is a synthetic peptide that functions as a growth hormone–releasing hormone (GHRH) analogue, formulated to stimulate the body’s natural production of growth hormone via pituitary activation. Unlike direct growth hormone suRead More
Dosage Strength:
5 Mg
Peptide Type:
Growth Hormone Releasing Hormone Analogue
Molecular Weight:
3357 Da
Category:
Peptide Hormone
Sermorelin 5 mg is a synthetic peptide that functions as a growth hormone–releasing hormone (GHRH) analogue, formulated to stimulate the body’s natural production of growth hormone via pituitary activation. Unlike direct growth hormone supplementation, Sermorelin works by enhancing endogenous hormone release in a more physiological manner. This peptide is widely used in clinical and research environments for studies related to endocrine function, metabolic balance, and growth hormone regulation. The 5 mg strength is provided in a lyophilized (freeze-dried) form to ensure stability, purity, and consistent performance.
Key Features
| Dosage Strength | 5 mg |
| Peptide Type | Growth hormone releasing hormone analogue |
| Molecular Weight | 3357 Da |
| Category | Peptide hormone |
| Primary Function | Stimulates HGH release |
| Target Gland | Pituitary |
| Mechanism | Activates GHRH receptors |
| Administration | Subcutaneous injection |
| Purity | 99% |
| Appearance | Lyophilized powder |
| Solubility | Water soluble |
| Shelf Life | 24 months |
| Packaging Type | Sterile vial option |
| Stability | Stable frozen |
| Application | Anti-aging research use |
| Target System | Endocrine |
| Delivery Form | Injection |
| Origin | Canada |
| Dosage Strength | 5 mg |
| Peptide Type | Growth hormone releasing hormone analogue |
| Molecular Weight | 3357 Da |
| Category | Peptide hormone |
| Primary Function | Stimulates HGH release |
| Target Gland | Pituitary |
| Mechanism | Activates GHRH receptors |
| Administration | Subcutaneous injection |
| Purity | 99% |
| Appearance | Lyophilized powder |
| Solubility | Water soluble |
| Shelf Life | 24 months |
| Packaging Type | Sterile vial option |
| Stability | Stable frozen |
| Application | Anti-aging research use |
| Target System | Endocrine |
| Delivery Form | Injection |
| Origin | Canada |
3316 E Richert AveFresno, CA 93726, USA
GET DIRECTION